Showing results 347 to 366 of 918
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2019 | Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae | Ebeyan, S.; Windsor, M.; Bordin, A.; Mhango, L.; Erskine, S.; Trembizki, E.; Mokany, E.; Tan, L.Y.; Whiley, D.; Guy, R.; Guy, R.; Wand, H.; Donovan, B.; Bell, S.; Kaldor, J.; Kong, M.; Conway, D.; Lafferty, L.; Ward, J.; Lahra, M.; et al. |
| 1998 | Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients | Cogill, Jan L.; Taylor, Paul J.; Westley, Ian S.; Morris, Raymond G.; Lynch, Stephen V.; Johnson, Anthony G. |
| 2023 | Evaluation of Uptake of COVID-19 Temporary Allied Health Services for Residential Aged Care in Australia | Caughey, G.E.; Collier, L.; Cations, M.; Wesselingh, S.; Inacio, M.C. |
| 2007 | Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats | Sevak, R.; Owens, W.; Koek, W.; Galli, A.; Daws, L.; France, C. |
| 2010 | Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta | Lewis, S.; Hutchinson, M.; Rezvani, N.; Loram, L.; Zhang, Y.; Maier, S.; Rice, K.; Watkins, L. |
| 2010 | Evidence that opioids may have toll-like receptor 4 and MD-2 effects | Hutchinson, M.; Zhang, Y.; Shridhar, M.; Evans, J.; Buchanan, M.; Zhao, T.; Slivka, P.; Coats, B.; Rezvani, N.; Wieseler-Frank, J.; Hughes, T.; Landgraf, K.; Chan, S.; Fong, S.; Phipps, S.; Falke, J.; Maier, S.; Leinwand, L.; Yin, H.; Rice, K.; et al. |
| 2010 | Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity | Hutchinson, M.; Loram, L.; Zhang, Y.; Shridhar, M.; Rezvani, N.; Berkelhammer, D.; Phipps, S.; Foster, P.; Landgraf, K.; Falke, J.; Rice, K.; Maier, S.; Yin, H.; Watkins, L. |
| 2004 | Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7 | Toutsikos, P.; Miners, J.; Stapleton, A.; Thomas, A.; Sallustio, B.; Knights, K. |
| 2008 | Evolution of Pharmacogenomics | Somogyi, A. |
| 2022 | Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients | Zahra, E.; Chen, R.; Nielsen, S.; Tran, A.D.; Santo, T.; Degenhardt, L.; Farrell, M.; Byrne, J.; Ali, R.; Larance, B. |
| 1995 | Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve | Barclay, Murray L.; Duffull, Stephen B.; Begg, Evan J.; Buttimore, R. C. |
| 1996 | Experience with recombinant Factor VIIa in Australia and New Zealand | McPherson, J.; Teague, L.; Lloyd, J. V. |
| 1998 | Experiences with continuous infusion of recombinant activated factor VII | Schulman, S.; d'Oiron, R.; Martinowicz, U.; Pasi, J.; Briquel, M.-E.; Mauser-Bunschoten, E.; Morfini, M.; Ritchie, B.; Goudemand, J.; Lloyd, John; McPherson, J.; Negrier, C.; Peerlinck, K.; Petrini, P.; Tussell, J. |
| 2008 | Experimental evidence for differential susceptibility: Dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. | Bakermans-Kranenburg, M.; Van IJzendoorn, M.; Buisman-Pijlman, F.; Mesman, J.; Juffer, F. |
| 2012 | Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids | Thomas, J.; Hutchinson, M. |
| 2011 | Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia | Hutchinson, M.; Shavit, Y.; Grace, P.; Rice, K.; Maier, S.; Watkins, L.; Barker, E.L. |
| 2018 | Exploring the structural diversity in inhibitors of α-Synuclein amyloidogenic folding, aggregation, and neurotoxicity | Das, S.; Pukala, T.; Smid, S. |
| 2008 | Exposure to opioid maintenance treatment reduces long-term mortality | Gibson, A.; Degenhardt, L.; Mattick, R.; Ali, R.; White, J.; O'Brien, S. |
| 2020 | Expression of key apoptotic genes in hepatocellular carcinoma cell line treated with etoposide-loaded graphene oxide | Gholami, A.; Emadi, F.; Nazem, M.; Aghayi, R.; Khalvati, B.; Amini, A.; Ghasemi, Y. |
| 2001 | Extensive protein carbonylation precedes acrolein-mediated cell death in mouse hepatocytes | Burcham, Philip Cyril; Fontaine, Frank R. |
